Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.67 USD | +1.52% | -10.79% | +5.91% |
May. 09 | Transcript : Phathom Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Phathom Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 42.22M | Sales 2025 * | 165M | Capitalization | 566M |
---|---|---|---|---|---|
Net income 2024 * | -318M | Net income 2025 * | -258M | EV / Sales 2024 * | 9.24 x |
Net cash position 2024 * | 176M | Net cash position 2025 * | 73.28M | EV / Sales 2025 * | 2.98 x |
P/E ratio 2024 * |
-1.84
x | P/E ratio 2025 * |
-2.6
x | Employees | 452 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.33% |
Latest transcript on Phathom Pharmaceuticals, Inc.
1 day | +1.52% | ||
1 week | -10.79% | ||
Current month | +7.09% | ||
1 month | -4.64% | ||
3 months | +55.72% | ||
6 months | +35.24% | ||
Current year | +5.91% |
Managers | Title | Age | Since |
---|---|---|---|
Azmi Nabulsi
FOU | Founder | 64 | 18-01-08 |
Terrie Curran
CEO | Chief Executive Officer | 55 | 19-07-31 |
David Socks
FOU | Founder | 49 | 18-01-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Fields
BRD | Director/Board Member | 69 | 19-09-26 |
Frank Karbe
BRD | Director/Board Member | 55 | 22-04-24 |
Michael Cola
CHM | Chairman | 64 | 19-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 9.67 | +1.52% | 600,598 |
24-05-10 | 9.525 | -5.60% | 856,132 |
24-05-09 | 10.09 | -0.10% | 1,113,582 |
24-05-08 | 10.1 | -1.37% | 537,546 |
24-05-07 | 10.24 | -5.54% | 533,650 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.91% | 566M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- PHAT Stock